CB vs GMED · P/E 14, rev $59.40B vs P/E 42, rev $1.55B
Chubb Ltd (CB) versus Globus Medical (GMED) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Globus Medical (GMED) is a medical devices company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
CB currently screens at market cap $114.26B and trailing P/E 13.7. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
Not investment advice. Open the CB and GMED stock pages for the full models.
Not investment advice.